Futamura A, Stratikos E, Olson S T, Gettins P G
Department of Biochemistry and Molecular Biology, College of Medicine, University of Illinois at Chicago 60612, USA.
Biochemistry. 1998 Sep 22;37(38):13110-9. doi: 10.1021/bi981234m.
Serpins inhibit proteinases by forming a kinetically trapped intermediate during a suicide substrate inhibition reaction. To determine whether the kinetic trap involves a repositioning of the P1 side chain of the serpin following formation of the initial Michaelis complex, we used the tryptophan of a P1 M-->W variant of human alpha1-proteinase inhibitor as a fluorescent reporter group of the environment of the P1 side chain. The P1W variant was a valid model serpin and formed SDS-stable complexes with both trypsin and chymotrypsin with a stoichiometry of inhibition close to 1.0. Rates of inhibition of chymotrypsin for wild-type and variant alpha1-proteinase inhibitor differred only approximately 1.8-fold. Rates of inhibition of trypsin were, however, 25-fold lower for the variant than for the wild-type inhibitor. Steady-state fluorescence spectra showed a change in environment for the P1 side chain upon forming both covalent complex with trypsin or chymotrypsin and noncovalent complex with anhydrochymotrypsin. The P1 environments in the chymotrypsin and anhydrochymotrypsin complexes were, however, different. Fluorescence quenching studies confirmed the burial of the P1 side chain upon formation of both the noncovalent and covalent complexes, but were not able to discriminate between the solvent accessibility in these complexes. Stopped-flow fluorescence measurements resolved the covalent intramolecular reaction that led to covalent complex and showed that, during the course of the covalent reaction, the environment of the P1 side chain changed consistent with a repositioning relative to residues of the proteinase active site as part of formation of the trap. This repositioning is likely to be a crucial part of the trapping mechanism.
丝氨酸蛋白酶抑制剂(Serpins)通过在自杀底物抑制反应过程中形成动力学捕获中间体来抑制蛋白酶。为了确定动力学捕获是否涉及初始米氏复合物形成后丝氨酸蛋白酶抑制剂P1侧链的重新定位,我们将人α1-蛋白酶抑制剂P1 M→W变体中的色氨酸用作P1侧链环境的荧光报告基团。P1W变体是一种有效的丝氨酸蛋白酶抑制剂模型,与胰蛋白酶和胰凝乳蛋白酶均形成SDS稳定的复合物,抑制化学计量比接近1.0。野生型和变体α1-蛋白酶抑制剂对胰凝乳蛋白酶的抑制速率仅相差约1.8倍。然而,变体对胰蛋白酶的抑制速率比野生型抑制剂低25倍。稳态荧光光谱显示,与胰蛋白酶或胰凝乳蛋白酶形成共价复合物以及与脱水胰凝乳蛋白酶形成非共价复合物时,P1侧链的环境发生了变化。然而,胰凝乳蛋白酶和脱水胰凝乳蛋白酶复合物中的P1环境不同。荧光猝灭研究证实了非共价和共价复合物形成时P1侧链的埋藏,但无法区分这些复合物中的溶剂可及性。停流荧光测量解析了导致共价复合物形成的共价分子内反应,并表明在共价反应过程中,P1侧链的环境发生了变化,这与作为捕获形成一部分相对于蛋白酶活性位点残基的重新定位一致。这种重新定位可能是捕获机制的关键部分。